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Aim To report a series of patients with lacrimal gland
lesions simulating the clinicoradiological features of
lacrimal gland pleomorphic adenoma (LGPA).
Methods Multicentre retrospective, interventional case
series. Clinical records of all patients with lesions
mimicking LGPA seen in ﬁve orbital units were reviewed.
Results The study included 14 patients (seven men and
seven women) with a mean age of 50.9 years. The
diagnosis of LGPA was made in all cases by experienced
orbital surgeons, based on clinicoradiological features,
and lacrimal gland excision was performed.
Postoperative histology revealed lymphoma (four
patients), chronic dacryoadenitis (three patients),
adenoid cystic carcinoma (two patients), Sjogren’s
syndrome (two patients), cavernous haemangioma (one
patient), benign lymphoid hyperplasia (one patient) and
granulomatous dacryoadenitis (one patient). Comparison
with the total number of histologically conﬁrmed LGPA
cases seen during the study period revealed that 22.6%
of cases of suspected LGPA were misdiagnosed based
on clinicoradiological criteria.
Conclusions Many different lesions may mimic the
clinicoradiological features of LGPA. The accepted
clinicoradiological criteria used for the diagnosis of LGPA
have a high false-positive rate, even in experienced
hands. Based on this study, the authors believe that ﬁne-
needle aspiration biopsy or intraoperative biopsy and
frozen section diagnosis may help reduce unnecessary
lacrimal gland excision.
Pleomorphic adenoma is the most common epithe-
lialtumourofthelacrimalglandaccountingformore
than 50% of primary epithelial tumours.
1 The diag-
nosis is based on well-deﬁned clinicoradiological
criteria and management is by total excision of the
tumour.
23Traditionalteachingadvocatesastrict‘no
biopsy’ policy for suspected lacrimal gland pleo-
morphic adenoma (LGPA) to minimise the risk of
recurrence or of malignant transformation.
2e5
Whereas the clinicoradiological criteria for the diag-
nosis ofLGPAarewell established, their speciﬁcity is
unknown, and given that the recommended treat-
ment involves excision of the lacrimal gland,
apreoperativemisdiagnosismayleadtounnecessary
or suboptimal surgery. We report a series of 14
patients in whom a preoperative diagnosis of LGPA
made on clinicoradiological criteria was not
supported by postoperative histology.
MATERIALS AND METHODS
This is a multicentre retrospective study of all
patients with lacrimal gland lesions mimicking
LGPA who were seen in ﬁve orbital units: Royal
Adelaide Hospital, January 1997 to October 2006
(two cases), Royal Victoria Eye and Ear Hospital,
January 1986 to October 2006 (four cases), Royal
North Shore Hospital, January 1996 to October
2006 (two cases), Vancouver General Hospital
(University of British Columbia), Orbit Clinic,
January 1994 to October 2006 (two cases) and
Sydney Eye Hospital, University of Sydney, January
2000 to October 2006 (four cases). One of the
patients in this series was the subject of a previous
publication (case 11).
6 Institutional Review Board/
Ethics Committee approval was obtained for this
study.
Experienced orbital surgeons (ﬁve different
orbital surgeons were involved in this study) eval-
uated all the patients and the preoperative diag-
nosis of LGPA was based on well-established
clinicoradiological features. In short, a long dura-
tion of symptoms and signs (>12 months), the
absence of pain, well-circumscribed lacrimal gland
mass on imaging that may indent the globe and the
absence of calciﬁcation all favoured a diagnosis of
LGPA. All patients underwent lateral orbitotomy
and excision of the lacrimal gland, usually with
preservation of part of the palpebral lobe in the
superolateral conjunctival fornix but removal of the
remainder of the gland including the overlying
periorbita.
We reviewed the medical records of these
patients to obtain the following data: patients’
demographics; duration of signs and symptoms;
clinical presentation; imaging ﬁndings on CT and
ultrasound; histological diagnosis and outcome.
The clinical and radiological ﬁndings were scored
according to the algorithm devised by Rose and
Wright
3 (see footnote to table 1). The medical
records in the ﬁve centres were also reviewed to
retrieve the total number of histologically
conﬁrmed LGPA seen during the period of this
study.
RESULTS
Our study included 14 patients (seven men and
seven women) with a mean age of 50.9 years
(median 50; range 34e68 years). The mean dura-
tion of symptoms before diagnosis was 17 months
(median 12 months; range 2 weeks to 48 months).
The CT ﬁndings in all cases were consistent with
a diagnosis of LGPA. The most common ﬁnding
was a well-circumscribed enlargement of the
lacrimal gland. Indentation of the globe was seen in
ﬁve cases and bone remodelling in three cases.
Ultrasound examination was performed in two
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clinical and radiological features of all the patients are detailed in
table 1. Applying Rose and Wright’s algorithm
3 to the 14 cases,
a mean score of 6.7 (range 4e8) was obtained, indicating a high
probability of LGPA.
All patients underwent lateral orbitotomy and excision of the
lacrimal gland for presumed pleomorphic adenoma. Histological
examination revealed the following diagnoses: non-Hodgkin’s
B-cell lymphoma: four cases; chronic dacryoadenitis: three cases;
Sjogren’s syndrome: two cases; adenoid cystic carcinoma: two
cases; granulomatous dacryoadenitis consistent with sarcoidosis:
one case; benign lymphoid hyperplasia: one case; cavernous
haemangioma: one case. In the last case, the diagnosis of
cavernous haemangioma was evident intraoperatively. Further
management was individualised according to the histological
diagnosis (table 1). Four patients (26.8%) developed complica-
tions following surgery, including dry eye, ptosis, lid retraction
and transient diplopia. The mean follow-up period was 3.6 years
(median 3 years; range 4 months to 10 years).
During the period of the study, 48 cases of histologically
conﬁrmed LGPA were seen in the ﬁve centres (Royal Adelaide
Hospital, seven cases; Royal Victoria Eye and Ear Hospital, 20
cases; Royal North Shore Hospital, four cases; Vancouver General
Hospital, 11 cases; and Sydney Eye Hospital, six cases). Using
ﬁgure 1, we calculated that 22.6% of patients were misdiagnosed
with LGPA based on the clinicoradiological criteria.
DISCUSSION
We present a series of patients with a variety of lacrimal gland
lesions, with clinical and radiological features simulating LGPA.
Although LGPA is the commonest epithelial tumour of the
lacrimal gland, it remains an uncommon tumour overall,
accounting for only 0.6% of all orbital cases.
7 Ninety per cent of
cases involve the orbital lobe of the lacrimal gland and the
remaining 10% involve the palpebral lobe.
1 It is an indolent
tumour, with fairly characteristic clinical and radiological
features as mentioned previously, and this allows almost all
cases to be diagnosed preoperatively. Deﬁnitive management is
by complete excision of the tumour, which in most cases
involves total removal of the orbital lobe of the lacrimal gland
along with the overlying periorbita. Incomplete removal of the
tumour leads to recurrence in a signiﬁcant number of cases,
sometimes after decades following the original surgery.
2e4 It is
also hypothesised that incomplete resection followed by recur-
rence (particularly multiple recurrences) may be a risk factor for
malignant transformation of the tumour
1. Biopsy is not
recommended as part of the preoperative work-up, and this
caveat against biopsy of lesions suspected to be LGPA arose from
the study by Font and Gamel in 1978.
4 They retrospectively
analysed 136 cases of LGPA and found that 27% of the cases
recurred. They calculated that previous biopsy would lead to
a 5-year recurrence rate of 32%. Later series by Ni and
coworkers,
5 Garrity and Henderson
2 and Rose and Wright
3 all
found an increased risk of recurrence following incomplete
excision, and based on this ﬁnding, all advised against preoper-
ative biopsy. Therefore, based on the foregoing studies, and also
because most LGPA present with characteristic clinical and
radiological signs allowing accurate preoperative diagnosis,
lacrimal gland excision without biopsy is the recommended
treatment.
2e5
A review of the recent literature on LGPA, however, suggests
that a signiﬁcant number of cases may present with symptoms
and signs not usually associated with this lesion. Sen and
coworkers
8 analysed a series of 32 cases of LGPA and found that
the duration of symptoms was less than 10 months in 28% of
cases. Calciﬁcation of the tumour, usually considered a sign of
malignancy, has also been described in LGPA
391 0and there is
a report of a case with bone destruction.
11 Degeneration within
LGPA giving the appearance of a cystic lesion is also described.
12
Conversely, symptoms and signs said to be characteristic of
LGPA may be seen in a number of other lacrimal gland lesions, as
evidenced by our series. Applying traditional clinicoradiological
criteria, such as the algorithm devised by Rose and Wright,
3 thus
often fails to distinguish between LGPA and other lacrimal gland
lesions. We would like to emphasise that despite a detailed
retrospective review of the case records, we were unable to
discover any features that may have pointed to a different
diagnosis in these cases, except perhaps for the short duration of
Figure 1 (A) A coronal CT image of
case 3 showing a mass in the right
lacrimal fossa indenting the globe with
a relatively poorly deﬁned inferior border
(white arrow). The outer margin of the
lesion with bone remodelling is marked
with a black arrow. The histological
diagnosis was follicular lymphoma. (B)
An axial CT image of case 10 showing
a well-circumscribed mass in the left
lacrimal fossa with remodelling of the
overlying bone (black arrow). The
histological diagnosis was adenoid
cystic carcinoma. (C) A coronal CT
image of case 4 showing a well-
circumscribed mass in the right lacrimal
fossa with remodelling of the overlying
bone (black arrow). The histological
diagnosis was mantle-cell lymphoma.
(D) A coronal CT image of case 13
demonstrating a mass in the left
lacrimal fossa, note the inferior border
of the mass (white arrow). The
histological diagnosis was reactive
lymphoid hyperplasia.
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to emphasise that ﬁve experienced orbital surgeons were
involved in this study and the rate of misdiagnosis of LGPA
based on clinicoradiological criteria was not signiﬁcantly
different between the centres.
Removal of the lacrimal gland may not result in serious
morbidity, except dry eye, especially as some of the lesions
mimicking LGPA, such as Sjogren’s syndrome and lymphoma,
may induce destruction of the lacrimal gland. However,
complete excision of the lacrimal gland exposes the patient to
unnecessary surgery, and also to the attendant morbidity and
expense of lateral orbitotomy, including possible diplopia and
temple volume deﬂation. This approach may also lead to
suboptimal management, for example, in patients with adenoid
cystic carcinoma, in whom more extensive initial surgery may
have been planned if a biopsy diagnosis had been available.
It is interesting to note that in their series on LGPA, Rose and
Wright
3 included 10 patients who had preoperative biopsy
followed by excision of the lacrimal gland and the biopsy track;
none of the patients developed recurrence over a mean follow-up
of 6 years. Sturgis and co-workers
13 included three patients with
LGPA in their paper on ﬁne-needle aspiration for orbital tumours
and noted no complications from the procedure. Rootman et al
10
have stated that although inadvertent incisional biopsies are
performed in 10e15% of cases, careful removal of the tumour
with the biopsy track is associated with a virtually zero recur-
rence rate. Fine-needle aspiration biopsy (FNAB) is used
routinely to diagnose salivary gland pleomorphic adenoma
(SGPA) (a tumour with similar natural history to LGPA), and
there has been no report of an increased risk of recurrence or
malignant transformation following this procedure.
14 15 At the
same time, it is evident that incomplete excision of SGPA leads
to a signiﬁcant risk of recurrence, as is the case for LGPA.
16 The
issue of malignant transformation is more controversial, with
studies suggesting that malignancy is inherently present in some
SGPA and is not inﬂuenced by recurrence or incomplete exci-
sion.
17 18 The same may also be true for LGPA.
19 The literature
on biopsy in LGPA has been reviewed in a recent perspective
article.
20 Since FNAB in salivary gland lesions has a predictive
accuracy of better than 80%
14 21 it is a reasonable option to
perform FNAB either preoperatively or intra-operatively in
suspected lacrimal gland LGPA. In the case of a negative or
suspicious result an intra-operative incisional biopsy with frozen
section diagnosis may be considered.
It is clear from our study that several different lesions of the
lacrimal gland can simulate LGPA clinically and radiologically. We
have also seen that traditional criteria used to diagnose LGPA may
have a high false-positive rate, and following a strict ‘no biopsy’
policy thus leads to unnecessary or suboptimal surgery in a signif-
icant proportion of patients. We therefore believe that preoperative
or intra-operative FNAB, or intra-operative incisional biopsy and
frozen section diagnosis are reasonable options for suspected
lacrimal gland tumours. If LGPA is diagnosed, lateral orbitotomy
with complete excision of the lacrimal gland together with excision
of the biopsy tract is recommended. We also feel that the role of
preoperative biopsy for these lesions needs to be re-evaluated.
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